InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-11.7%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by McClenahan Thomas Samuel, Vice-Président Exécutif, Conseiller Général et Secrétaire de l'entreprise. Director active across 1 company, notably MASIMO CORP. Aggregated, 9 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €369k. Activity tracked since 30 April 2021. The latest transaction was filed on 28 February 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
1,004 shares0Common StockSEC:0000937556-24-000023:0
5,016 shares0Common StockSEC:0000937556-23-000022:0
9,302 shares0Common StockSEC:0000937556-22-000059:0
2,000 shares0Common StockSEC:0000937556-22-000004:0
2,000 shares0Common StockSEC:0000937556-22-000004
500 shares@ US$214.4023.9% of flowCommon StockSEC:0000937556-21-000095
Ideal exit: 5 Feb 2022 (T+270)
500 shares@ US$214.400.0009% mcap23.9% of flowCommon StockSEC:0000937556-21-000095:0
Ideal exit: 5 Feb 2022 (T+270)
500 shares@ US$233.240.0010% mcap26.1% of flowCommon StockSEC:0000937556-21-000091:0
Ideal exit: 25 Jan 2022 (T+270)
500 shares@ US$233.2426.1% of flowCommon StockSEC:0000937556-21-000091
Ideal exit: 25 Jan 2022 (T+270)
9 of 9 declarations
About McClenahan Thomas Samuel
Thomas Samuel McClenahan serves as Executive Vice President, General Counsel, and Corporate Secretary at Masimo Corp, an innovative company in the medical technology field. In his role, he oversees legal affairs and regulatory compliance, ensuring that the company adheres to all applicable laws and regulations. Thomas plays a key role in managing legal risks and supporting the company's strategic initiatives.
